Article
[Multicentric evaluation of MDR phenotype in leukemia: intermediate analysis of the French study].
Bulletin du cancer - 1 Aug 1996
Perrot J Y, Faussat A M, Zhou D C, Zittoun R, Robert J, Marie J P
Abstract excerpt
Thirty-six French centres are involved in an evaluation of the techniques used for MDR phenotype measurement. Until now, 14 samples of various kinds of leukemia (mainly acute myelogenous leukemia) and three cell lines with different levels of resistance were sent by one centre and tested. MRK16 antibody was used for flow cytometry and immunocytochemistry, RNA was measured by RT-PCR, rhodamine or anthracyclin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
